24 /100
LOW RISK
Score updated May 30, 2026

PTIX — Protagenic Therapeutics, Inc. Dilution Risk Tracker

Track PTIX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PTIX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.65 below $1 exchange minimum
🔔 Track PTIX — Get forecast alerts →

💹 Market Data

Market Cap$982.9K
Shares Outstanding1.81M
FloatN/A
Cash$1.78M
Debt$4.00M
Short InterestN/A

🏛 Institutional Holdings

4.6% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track PTIX for full holder detail →

📉 Short Interest

Short Interest13.0K
Days to Cover1.1
% of FloatN/A
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2023
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track PTIX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PTIX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADT
🔬 More Research for PTIX
📊 PTIX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PTIX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.